4.2 Article

Multiplex Analysis of 230 Medications and 30 Illicit Compounds in Dried Blood Spots and Urine

Journal

JOURNAL OF ANALYTICAL TOXICOLOGY
Volume 45, Issue 6, Pages 581-592

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/jat/bkaa125

Keywords

-

Funding

  1. Alcala Testing and Analysis Services (ATAS)

Ask authors/readers for more resources

The study presents a novel method for qualitative and quantitative multiplex analysis of drugs and illicit substances in DBS and urine samples, demonstrating its reliability and effectiveness in extended medication reconciliation testing while also detecting drug-drug interactions. Experimental results show that this method is a valuable tool in aiding the detection of medications and drug interactions.
Drugs of abuse and medication reconciliation testing can benefit from analysis methods capable of detecting a broader range of drug classes and analytes. Mass spectrometry analysis of a wide variety of commonly prescribed medications and over-the-counter drugs per sample also allows for application of a drug-drug interaction (DDI) algorithm to detect adverse drug reactions. In order to prevent adulteration of commonly collected clinical samples such as urine, dried blood spots (DBS) present a reliable alternative. A novel method is described for qualitative and quantitative multiplex analysis of 230 parent drugs, 30 illicit drugs and 43 confirmatory metabolites by HPLC-MS-MS This method is applicable to DBS specimens collected by volumetric absorptive microsamplers and confirmable in urine specimens. A patient cohort (n = 67) providing simultaneous urine specimens and DBS resulted in 100% positive predictive values of medications or illicits confirmed by detection of a parent drug and/or its metabolite during routine medication adherence analysis. An additional 5,508 DBS specimens screened (n = 5,575) showed 5,428 (97%) with an inconsistent positive compared to the provided medication list (including caffeine, cotinine or ethanol metabolites), 29 (0.5%) with no medication list and no unexpected positive results (consistent negative) and 22 (0.4%) showed all positive results matching the provided medication list (consistent positive). A DDI algorithm applied to all positive results revealed 17% with serious and 56% with moderate DDI warnings. Comprehensive DBS analysis proves a reliable alternative to urine drug testing for extended medication reconciliation, with the added advantage of detecting DDIs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available